Weighted Average Number of Shares Outstanding, Diluted of Arcus Biosciences, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Arcus Biosciences, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • Arcus Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 107,400,000, a 19% increase year-over-year.
  • Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 107,400,000, a 19% increase from 2024.
  • Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 90,100,000, a 22% increase from 2023.
  • Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74,000,000, a 2.8% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Arcus Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 107,400,000 +17,300,000 +19% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 106,500,000 +15,100,000 +17% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 106,500,000 +15,400,000 +17% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 98,400,000 +12,200,000 +14% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 90,100,000 +16,100,000 +22% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 91,400,000 +16,800,000 +23% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025 2025 Q3
Q2 2024 91,100,000 +17,900,000 +24% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 86,200,000 +13,200,000 +18% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 74,000,000 +2,000,000 +2.8% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 74,600,000 +2,400,000 +3.3% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 73,200,000 +1,400,000 +2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 73,000,000 +1,800,000 +2.5% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 72,000,000 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 72,200,000 +2,089,862 +3% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 71,800,000 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 71,200,000 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q3 2021 70,110,138 +4,964,431 +7.6% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q4 2020 63,527,932 01 Oct 2020 31 Dec 2020 10-K 25 Feb 2021 2020 FY
Q3 2020 65,145,707 +21,206,426 +48% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 48,556,843 01 Apr 2020 30 Jun 2020 10-K 25 Feb 2021 2020 FY
Q1 2020 44,282,607 01 Jan 2020 31 Mar 2020 10-K 25 Feb 2021 2020 FY
Q3 2019 43,939,281 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3

Arcus Biosciences, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 107,400,000 +17,300,000 +19% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 90,100,000 +16,100,000 +22% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 74,000,000 +2,000,000 +2.8% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 72,000,000 -2,000,000 -2.7% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 74,000,000 +19,200,000 +35% 01 Jan 2021 31 Dec 2021 10-K 21 Feb 2024 2023 FY
2020 54,800,000 +10,974,009 +25% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 43,825,991 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.